Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+8.92%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$26.5B
AUM Growth
+$3.48B
(+15%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
4.77%
Top 10 Holdings %
Top 10 Hldgs %
14.04%
Holding
1,543
New
396
Increased
301
Reduced
281
Closed
335
Top Buys
| 1 |
Salesforce
CRM
|
+$444M |
| 2 |
Meta Platforms (Facebook)
META
|
+$327M |
| 3 |
Broadcom
AVGO
|
+$281M |
| 4 |
Amazon
AMZN
|
+$270M |
| 5 |
Uber
UBER
|
+$241M |
Top Sells
| 1 |
T-Mobile US
TMUS
|
+$270M |
| 2 |
Palo Alto Networks
PANW
|
+$232M |
| 3 |
AstraZeneca
AZN
|
+$222M |
| 4 |
Ross Stores
ROST
|
+$201M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$173M |
Sector Composition
| 1 | Healthcare | 21.16% |
| 2 | Technology | 20.34% |
| 3 | Consumer Discretionary | 12.14% |
| 4 | Industrials | 8.84% |
| 5 | Financials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Opendoor
OPEN
$4.5B
| $3.51M | 0.01% |
3,024,630
-906,399
| -23% | -$1.05M |
|
652
Brookfield
BN
$99B
| $3.5M | 0.01% |
111,200
-24,623
| -18% | -$775K |
|
653
Milestone Pharmaceuticals
MIST
$146M
| $3.47M | 0.01% |
+875,000
| New | +$3.47M |
|
654
Protagonist Therapeutics
PTGX
$3.63B
| $3.45M | 0.01% |
316,500
-2,221,493
| -88% | -$24.2M |
|
655
Apple Hospitality REIT
APLE
$2.99B
| $3.43M | 0.01% |
217,085
-66,553
| -23% | -$1.05M |
|
656
Vicor
VICR
$2.25B
| $3.42M | 0.01% |
+63,645
| New | +$3.42M |
|
657
Astria Therapeutics
ATXS
$425M
| $3.35M | 0.01% |
+225,000
| New | +$3.35M |
|
658
Zscaler
ZS
$44B
| $3.28M | 0.01% |
+29,300
| New | +$3.28M |
|
659
Delek US
DK
$1.92B
| $3.27M | 0.01% |
121,000
-339,115
| -74% | -$9.16M |
|
660
RxSight
RXST
$400M
| $3.27M | 0.01% |
257,700
+20,059
| +8% | +$254K |
|
|
CMRC
661
Commerce.com, Inc. Series 1 Common Stock
CMRC
$374M
| $3.25M | 0.01% |
+372,400
| New | +$3.25M |
|
662
YPF
YPF
$10.6B
| $3.25M | 0.01% |
+353,700
| New | +$3.25M |
|
663
nVent Electric
NVT
$14.7B
| $3.25M | 0.01% |
84,479
-75,921
| -47% | -$2.92M |
|
664
Stifel
SF
$11.5B
| $3.22M | 0.01% |
+55,200
| New | +$3.22M |
|
665
Utilities Select Sector SPDR Fund
XLU
$20.7B
| $3.19M | 0.01% |
+45,300
| New | +$3.19M |
|
666
Core & Main
CNM
$9.43B
| $3.17M | 0.01% |
+164,400
| New | +$3.17M |
|
667
4D Molecular Therapeutics
FDMT
$326M
| $3.09M | 0.01% |
139,300
-159,700
| -53% | -$3.55M |
|
668
Brookfield Infrastructure Partners
BIP
$14.2B
| $3.08M | 0.01% |
+99,500
| New | +$3.08M |
|
669
Under Armour
UAA
$2.16B
| $3.04M | 0.01% |
+299,664
| New | +$3.04M |
|
670
Leonardo DRS
DRS
$10.7B
| $3.04M | 0.01% |
+237,960
| New | +$3.04M |
|
671
TripAdvisor
TRIP
$2.06B
| $3M | 0.01% |
166,900
-18,900
| -10% | -$340K |
|
672
ReNew
RNW
$2.78B
| $2.99M | 0.01% |
543,000
+112,800
| +26% | +$620K |
|
673
Genworth Financial
GNW
$3.5B
| $2.93M | 0.01% |
554,700
+323,300
| +140% | +$1.71M |
|
674
Cidara Therapeutics
CDTX
$1.6B
| $2.93M | 0.01% |
193,400
| – | – |
|
675
Toast
TOST
$23.9B
| $2.92M | 0.01% |
+161,800
| New | +$2.92M |
|